Results 141 to 150 of about 1,825,669 (338)

Evidence for the impact of Reactive oxygen species on the control of branching in Neurospora crassa [PDF]

, 2011
In preliminary screens, several functions, most notably, genes involved in the control of reactive oxygen species (ROS), were identified as playing a role in the process of growth rate compensation of branch density.
Watters, Michael, Yablonowski, Jacob, Zapata, Alex   +2 more
core   +1 more source

ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells

Oxidative Medicine and Cellular Longevity, 2019
Reactive oxygen species (ROS) are by-products of normal cell activity. They are produced in many cellular compartments and play a major role in signaling pathways.
A. Snezhkina, A. Kudryavtseva, O. Kardymon, M. Savvateeva, N. Melnikova, G. Krasnov, A. Dmitriev   +6 more
semanticscholar   +1 more source

LOXHD1 and RHOB Expression by Monocytes Predicts Progressive Systemic Sclerosis associated Interstitial Lung Disease

Arthritis Care &Research, Accepted Article.
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla, Robert Lafyatis, Kevin F Gibson, Christina Morse, Eleanor Valenzi, Xiaoping Chen, Xiaoyun Li, Yanwu Zhao, Yongseok Park, Dana Ascherman, Jonathan Minden, Robyn Domsic, Yingze Zhang, Daniel J Kass   +13 more
wiley   +1 more source

MgATPase Activity is Dispensable for the Pharmacological Regulation of the Functional Effects of the KATP Channels Opening in Brain Mitochondria

Frontiers in Bioscience-Landmark
Background: The mechanisms underlying the effects of pharmacological mitochondrial ATP-sensitive K+ channel (mKATP) channel openers on the functional effects of the mKATP channels opening remain disputable.
Olga V. Akopova, Anton Smirnov
doaj   +1 more source

Jolkinolide B induces reactive oxygen species accumulation and endoplasmic reticulum stress and inhibits MAPK and AKT signaling activation in renal cancer cells [PDF]

Journal of Men's Health
To investigate the impact of Jolkinolide B (JB) on renal cell carcinoma (RCC), we treated RCC cell lines with various concentrations of JB (0, 5, 25, 50 and 100 μM) for 24 hours and assessed cell viability using the cell counting kit-8 (CCK-8 ...
Xuan Wu, Sijing Pan, Xiujuan Li, Jing Liu, Zhigang Wang, Yinghong Lei, Qunchao Mei   +6 more
doaj   +1 more source

PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation [PDF]

, 2009
Valentina Appierto, Paola Tiberio, Maria Grazia Villani, Elena Cavadini, Franca Formelli   +4 more
openalex   +1 more source

Luteolin prevents TNF-α-induced NF-κB activation and ROS production in cultured human placental explants and endothelial cells [PDF]

, 2023
Adrian C. Eddy, Augustine Rajakumar, Frank T. Spradley, Joey P. Granger, Sarosh Rana   +4 more
openalex   +1 more source

Reactive oxygen species induced by water containing nano-bubbles and its role in the improvement of barley seed germination [PDF]

, 2014
This paper was presented at the 4th Micro and Nano Flows Conference (MNF2014), which was held at University College, London, UK. The conference was organised by Brunel University and supported by the Italian Union of Thermofluiddynamics, IPEM, the ...
4th Micro and Nano Flows Conference (MNF2014), Liu, S, Makino, Y, Oshita, S   +3 more
core  

Cellular death, reactive oxygen species (ROS) and diabetic complications

Cell Death and Disease, 2018
Chronic or intermittent hyperglycemia is associated with the development of diabetic complications. Several signaling pathways can be altered by having hyperglycemia in different tissues, producing oxidative stress, the formation of advanced glycation ...
C. Volpe, Pedro Henrique Villar-Delfino, Paula Martins Ferreira dos Anjos, J. A. Nogueira-Machado   +3 more
semanticscholar   +1 more source

Re‐thinking Strategies for a Pharmaceutical Approach to Pain‐related to Connective Tissue Related Raynaud's Phenomenon in the United States

Arthritis Care &Research, Accepted Article.
Introduction There are no Food and Drug Administration (FDA) approved therapies for Raynaud's phenomenon (RP) treatment in the United States (U.S.). Clinical trials have been challenged by study design. Important advances in RP patient reported outcome measures and mechanistic quantification allows RP‐related pain characterization.
Tracy M Frech, Charles G Frech, W David Merryman, Andrew Sternlicht, Justin Baba   +4 more
wiley   +1 more source